🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Drugs Controller General of India (DCGI) has granted approval for Ascim...
Status
Completed
Location
Novartis Investigative Site
Start Date
2024-11-28
Trial ID
NCT06427811
Treatments Being Tested
To evaluate efficacy, safety and pharmacokinetic profile of asciminib 40mg+...
Status
Completed
Location
Georgia Regents University
Start Date
2018-11-22
Trial ID
NCT03578367
Treatments Being Tested
This study was a multicenter Phase IIIb open-label, three-cohort study of a...
Status
Completed
Location
Alaska Oncology and Hematology
Start Date
2021-05-25
Trial ID
NCT04666259
Treatments Being Tested
The purpose of the study is to optimize the treatment of asciminib in patie...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-10-13
Trial ID
NCT04948333
Treatments Being Tested
This is a single arm phase II study that will enroll a minimum of 47 subjec...
Status
Recruiting
Location
The Barbara Ann Karmanos Cancer Institute
Start Date
2021-11-11
Trial ID
NCT04838041
Treatments Being Tested
The purpose of this Chinese bridging study is to evaluate the efficacy, saf...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-12-06
Trial ID
NCT04795427
Treatments Being Tested
The purpose of this pivotal study was to compare the efficacy of asciminib ...
Status
Completed
Location
University of Chicago Hospital
Start Date
2017-10-26
Trial ID
NCT03106779